Prospects of β‐Secretase Inhibitors for the Treatment of Alzheimer’s Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1860-7187|10|9|1463-1466

ISSN： 1860-7179

Source： CHEMMEDCHEM, Vol.10, Iss.9, 2015-09, pp. : 1463-1466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi‐ and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β‐Amyloid (Aβ) Aggregation

By  

CHEMMEDCHEM, Vol. 10, Iss. 6, 2015-06 ,pp. : 1040-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

6‐Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease

By  

CHEMMEDCHEM, Vol. 10, Iss. 11, 2015-11 ,pp. : 1863-1874

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐(2‐(Piperazin‐1‐yl)phenyl)arylamide Derivatives as β‐Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four‐Component Reaction and Biological Evaluation

By  

ARCHIV DER PHARMAZIE (ELECTRONIC), Vol. 348, Iss. 5, 2015-05 ,pp. : 330-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Electroanalysis of Natural Compounds as Copper Chelating Agents for Alzheimer’s Disease Therapy

By  

ELECTROANALYSIS (ELECTRONIC), Vol. 27, Iss. 11, 2015-11 ,pp. : 2670-2678

John Wiley & Sons Inc

Access to resources Recommend Favorite

β-Secretase (BACE1) inhibitory property of loganin isolated from Corni fructus

By Youn Kumju   Jeong Woo-Sik   Jun Mira  

Natural Product Research, Vol. 27, Iss. 16, 2013-08 ,pp. : 1471-1474

Taylor & Francis Ltd

Access to resources Recommend Favorite